Status:
UNKNOWN
Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users
Lead Sponsor:
Department of Medical Services Ministry of Public Health of Thailand
Conditions:
Abnormal Uterine Bleeding
Tranexamic Acid
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Abnormal uterine bleeding is the most common problems to discontinue Depo-medroxyprogesterone acetate (DMPA) in Thailand. This clinical trial use to provide drug to stop abnormal uterine bleeding from...
Detailed Description
Abnormal uterine bleeding is the most common problems to discontinue Depo-medroxyprogesterone acetate (DMPA) in Thailand. After discontinue DMPA, patients have not used any method. Unwanted pregnancy ...
Eligibility Criteria
Inclusion
- Abnormal uterine bleeding more than 7 days after first DMPA injection
- Provide inform consent with patient
- Can understand thai language
Exclusion
- Have contraindication to use Tranexamic acid and estrogen such as hypertension, Stroke, MI, DM, Renal disease, Liver disease, CA breast etc.
- Have pathology in uterus from pelvic examination, pap smear and ultrasound
- Current pelvic infection
- Postpartum less than 6 months
- History deep vein thrombosis
- Breastfeeding
Key Trial Info
Start Date :
September 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2024
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06067217
Start Date
September 30 2023
End Date
August 30 2024
Last Update
November 18 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Krittiporn Mahachiraphat
Bangkok, Ratchathewi, Thailand, 10400
2
Krittiporn Mahachiraphat, M.D.
Phaya Thai, Ratchathewi, Thailand, 10400